Telix Pharmaceuticals has secured landmark approval from the United States Food and Drug Administration for Pixclara, making ...

AusBiotech has welcomed concessions to changes to the R&D Tax Incentive and Capital Gains Tax but remains concerned about the ...

The controlled release covers Promarker D, a test that assesses a patient's risk of developing diabetic kidney disease up to ...

SKN, will advance to an extension clinical study in patients with cutaneous lupus erythematosus, a painful, disfiguring skin ...

Six patients who had lived with binge eating disorder for as long as two decades sat down for two infusions of an ...

A hospital in Madrid has reached a notable milestone for OncoSil Medical, with the Australian medical device company ...

CLINUVEL, a Melbourne- and Singapore-based biopharmaceutical company, has completed development of a proprietary single-use ...

Radiopharm Theranostics has reported encouraging early results from a Phase 1 imaging trial of its experimental agent RAD301 ...

Arovella Therapeutics has taken a step toward treating blood cancer patients with donor-derived cells rather than their own, ...

Vitrafy Life Sciences has secured its first foothold in the United States cell and gene therapy market through an agreement ...

The grant, announced by Neurizon, will finance an Expanded Access Protocol for NUZ-001, the company's lead drug candidate for ...

ENA Respiratory has welcomed $2.98 million in funding from Biointelect Venturer to support its first Australian study of INNA ...